Urinary biomarker assessment quantitates kidney function and injury through urine protein, casts, and enzyme measurement. Proteinuria levels indicate glomerular dysfunction. Tubular enzyme elevation suggests epithelial damage. Casts visualisation confirms tubular involvement. Biomarker elevation precedes creatinine changes.
Regulatory monitoring establishes baseline values. Progressive elevation indicates worsening function. Early intervention prevents progression. Regulatory submissions incorporate biomarker data. Post-approval monitoring employs biomarkers.
General Biopharmaceutical Concepts
Urinary Biomarker Assessment
Urinary biomarker assessment measures biomarkers in urine to evaluate disease status, organ function or therapeutic response using a non-invasive approach.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →